PFS Partners’s Zimmer Biomet ZBH Stock Holding History

PFS Partners’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.79K	Hold	21	–	–	﹤0.01%	544
2026 Q1	$1.89K	Hold	21	–	–	﹤0.01%	522
2025 Q4	$1.87K	Hold	21	–	–	﹤0.01%	523
2025 Q3	$2.05K	Hold	21	–	–	﹤0.01%	503
2025 Q2	$1.9K	Hold	21	–	–	﹤0.01%	463
2025 Q1	$2.36K	Hold	21	–	–	﹤0.01%	388
2024 Q4	$2.2K	Hold	21	–	–	﹤0.01%	400
2024 Q3	$2.25K	Hold	21	–	–	﹤0.01%	401
2024 Q2	$2.26K	Hold	21	–	–	﹤0.01%	389
2024 Q1	$2.75K	Hold	21	–	–	﹤0.01%	398
2023 Q4	$2.54K	Hold	21	–	–	﹤0.01%	397
2023 Q3	$2.34K	Hold	21	–	–	﹤0.01%	397
2023 Q2	$3.04K	Hold	21	–	–	﹤0.01%	397
2023 Q1	$2.69K	Hold	21	–	–	﹤0.01%	317
2022 Q4	$2.65K	Hold	21	–	–	﹤0.01%	303
2022 Q3	$2.17K	Hold	21	–	–	﹤0.01%	300
2022 Q2	$2.17K	Hold	21	–	–	﹤0.01%	293
2022 Q1	$2.64K	Sell	21 -1	-5%	-$121	﹤0.01%	298
2021 Q4	$2.62K	Buy	+22	New	+$2.88K	﹤0.01%	297

Other funds holding ZBH

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

PFS Partners's ZBH Position: Q2 2026 in Review

PFS Partners held its Zimmer Biomet (ZBH) position steady in Q2 2026 at 21 shares worth $1.79K. The position accounts for ﹤0.01% of the portfolio, ranked #544.

PFS Partners first reported a position in ZBH in Q4 2021 and has held it in 19 quarters since. The position peaked at $3.04K in Q2 2023. 909 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

PFS Partners held 21 shares of Zimmer Biomet worth $1.79K as of Q2 2026.
PFS Partners left its Zimmer Biomet share count unchanged in Q2 2026.
Zimmer Biomet made up ﹤0.01% of PFS Partners's portfolio in Q2 2026, its #544 holding.
PFS Partners first reported a position in Zimmer Biomet in Q4 2021 and has held it in 19 quarters since.
PFS Partners's Zimmer Biomet position peaked at $3.04K in Q2 2023.
909 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on PFS Partners's 13F filing for Q2 2026, filed 20 Jul 2026.